Sumitomo Pharma Co., Ltd. (DNPUF)
8.405
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Sumitomo Pharma Total Liabilities (Quarterly) : 2.685B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.685B |
| March 31, 2026 | 3.219B |
| December 31, 2025 | 3.359B |
| September 30, 2025 | 3.472B |
| June 30, 2025 | 3.857B |
| March 31, 2025 | 3.833B |
| December 31, 2024 | 4.365B |
| September 30, 2024 | 4.793B |
| June 30, 2024 | 4.401B |
| March 31, 2024 | 4.965B |
| December 31, 2023 | 5.081B |
| September 30, 2023 | 4.938B |
| June 30, 2023 | 5.007B |
| March 31, 2023 | 5.470B |
| December 31, 2022 | 5.104B |
| September 30, 2022 | 4.762B |
| June 30, 2022 | 4.994B |
| March 31, 2022 | 5.227B |
| December 31, 2021 | 5.472B |
| September 30, 2021 | 5.546B |
| June 30, 2021 | 5.748B |
| March 31, 2021 | 5.972B |
| December 31, 2020 | 6.492B |
| September 30, 2020 | 5.709B |
| June 30, 2020 | 5.556B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.749B |
| December 31, 2019 | 5.455B |
| September 30, 2019 | 2.715B |
| June 30, 2019 | 2.957B |
| March 31, 2019 | 3.041B |
| December 31, 2018 | 3.027B |
| September 30, 2018 | 3.040B |
| June 30, 2018 | 3.182B |
| March 31, 2018 | |
| December 31, 2017 | 2.887B |
| September 30, 2017 | 2.954B |
| June 30, 2017 | 2.993B |
| March 31, 2017 | 2.991B |
| December 31, 2016 | 2.377B |
| September 30, 2016 | 2.195B |
| June 30, 2016 | 2.264B |
| March 31, 2016 | 2.324B |
| December 31, 2015 | 2.399B |
| September 30, 2015 | 2.258B |
| June 30, 2015 | 2.199B |
| March 31, 2015 | 2.173B |
| December 31, 2014 | 2.207B |
| September 30, 2014 | 2.286B |
| June 30, 2014 | 2.391B |
| March 31, 2014 | 2.529B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 49.87B |
| Daiichi Sankyo Co., Ltd. | 14.84B |
| Eisai Co., Ltd. | 3.845B |
| Chugai Pharmaceutical Co., Ltd. | 2.598B |
| Santen Pharmaceutical Co., Ltd. | 717.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.198B |
| Shareholders Equity (Quarterly) | 2.514B |
| Debt to Equity Ratio | 0.3932 |
| Current Ratio | 1.212 |
| Net Debt Paydown Yield | 5.27% |